tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX

Lexicon Pharmaceuticals (LXRX) Income Statement

1,284 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q2 2023), Lexicon Pharmaceuticals's total revenue was $317.00K, an increase of 805.71% from the same quarter last year. In Q2, Lexicon Pharmaceuticals's net income was $-44.90M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 356.00K$ 1.20M$ 139.00K$ 298.00K$ 24.00M$ 322.07M
Cost of Revenue
$ 8.00K$ 85.00K--$ 1.93M$ 3.23M
Gross Profit
$ 30.29M$ 1.12M$ 139.00K$ 298.00K$ 22.07M$ 318.84M
Operating Expense
$ 68.84M$ 185.97M$ 100.90M$ 87.39M$ 200.85M$ 148.76M
Operating Income
$ -15.66M$ -171.75M$ -100.90M$ -87.39M$ -178.78M$ 170.08M
Net Non Operating Interest Income Expense
$ -4.07M-$ -2.78M$ -802.00K$ -11.78M$ -17.33M
Other Income Expense
$ -2.33M$ -7.83M$ -1.60M$ -134.00K$ 131.99M$ -28.64M
Pretax Income
$ -17.36M$ -177.12M$ -101.94M$ -87.76M$ -58.57M$ 124.12M
Tax Provision
-$ -4.72M$ -238.00K$ -368.00K$ 0.00$ -6.01M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -77.38M$ -177.12M$ -101.94M$ -87.76M$ -58.57M$ 130.13M
Basic EPS
$ -0.52$ -0.80$ -0.62$ -0.60$ -0.53$ 1.23
Diluted EPS
$ -0.52$ -0.80$ -0.62$ -0.60$ -0.53$ 1.16
Basic Average Shares
$ 568.70M$ 221.13M$ 165.73M$ 145.65M$ 110.84M$ 106.22M
Diluted Average Shares
$ 568.70M$ 221.13M$ 165.73M$ 146.26M$ 110.84M$ 116.75M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 68.85M$ 186.06M$ 100.90M$ 87.39M$ 202.78M$ 151.99M
Net Income From Continuing And Discontinued Operation
$ -100.22M$ -177.12M$ -101.94M$ -87.76M$ -58.57M$ 130.13M
Normalized Income
$ -11.47M$ -181.84M--$ -190.56M$ 151.04M
Interest Expense
$ 864.00K---$ 14.54M$ 20.68M
EBIT
$ -12.71M$ -177.12M$ -99.16M$ -86.96M$ -44.03M$ 144.79M
EBITDA
$ -11.81M$ -174.79M$ -98.74M$ -86.96M$ -41.10M$ 148.45M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis